Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EACR 2012 /
The ceRNA Hypothesis and the non-coding revolution in cancer research and therapy

7th - 10th Jul 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 19.07.12
Views: 8408

Prof Pier Paolo Pandolfi - Harvard Medical School, Boston, USA

Prof Pandolfi talks to ecancer at the 22nd European Association for Cancer Research meeting, June 2012, Barcelona.

Only 2 % of the transcribed genome that encodes for protein has currently been functionalised, so there is a huge potential for investigation in to RNA for cancer treatment as well as other diseases.

Translating the 'code' of RNA allows us to predict which RNA interacts where and understanding the relationships between protein-coding genes and non-protein coding genes will lead to better diagnostics and risk prediction.


Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation